Beta Bionics to Present at the Bank of America Securities Health Care Conference
Rhea-AI Summary
Beta Bionics (Nasdaq: BBNX) will present at the Bank of America Securities Health Care Conference in Las Vegas on Tuesday, May 12, 2026 at 2:20 PM ET (11:20 AM PT).
A live audio webcast will be available on the company’s Investors & Events page at https://investors.betabionics.com and will be archived there for future replay.
Positive
- None.
Negative
- None.
News Market Reaction – BBNX
In the Apr 28 session, BBNX declined 5.35%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 21 | Earnings and guidance | Positive | -4.4% | Strong Q1 2026 growth and raised full-year revenue and margin guidance. |
| Mar 31 | Product feature launch | Positive | +1.6% | Launch of Bionic Insights to enhance clinical data interpretation for iLet users. |
| Mar 30 | Earnings date notice | Neutral | +1.6% | Announcement of timing and access details for Q1 2026 results call. |
| Feb 19 | Conference presentation | Neutral | +1.8% | Notice of management presentation at the TD Cowen health care conference. |
| Feb 17 | Earnings and guidance | Positive | -2.6% | Strong 2025 revenue growth, larger installed base, and initial 2026 guidance. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent strong earnings and guidance raises have twice been followed by negative next-day moves, while product and conference news have seen modest positive reactions.
This announcement fits a pattern of Beta Bionics communicating regularly with investors through conferences and product updates. Recent history includes strong Q4 2025 and Q1 2026 results with raised 2026 guidance, yet shares fell 2.58% and 4.4% after those earnings. In contrast, product news such as Bionic Insights and prior conference participation saw modest gains around 1.6–1.8%, suggesting operational updates and visibility events have been received more constructively than earnings releases.
AI-generated analysis. How Rhea-AI works. Not financial advice.
IRVINE, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at the Bank of America Securities Health Care Conference in Las Vegas on Tuesday, May 12, 2026 at 2:20 pm Eastern Time (11:20 am Pacific Time).
A live audio webcast of the presentation will be available on the Company’s website in the “Investors—Events & Presentations” section at https://investors.betabionics.com, and will be archived there for future replay following the event.
About Beta Bionics
Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The iLet Bionic Pancreas is the first FDA-cleared insulin delivery device that autonomously determines every insulin dose and offers the potential to substantially improve overall outcomes across broad populations of PWD. To learn more, visit www.betabionics.com.
Investor Relations:
Blake Beber
Head of Investor Relations
ir@betabionics.com
Media and Public Relations:
Felicia Sanborn
Vice President of Marketing
media@betabionics.com
Source: Beta Bionics, Inc.
